<p>Comparing blood glucose concentrations in naïve and taVNS treated ZDF rats (a, n = 6 each), in pinealectomized ZDF rats (immediately after pinealectomy operation) with or without taVNS treatment (b, n = 5 each), and in naïve, taVNS, and AMEA treated ZL rats (c, n = 4 each). ZL, ZDF, naïve ZL or ZDF rats; taVNS, taVNS treated rats; AMEA, auricular margin electroacupuncture treated rats; Px, pinealectomized rats; Px/VS, taVNS treated pinealectomized rats; Mel, daily melatonin injected rats. Bas, baseline (before taVNS); W1–W5, 1–5 weeks after consecutive taVNS treatment. *, **, *** P<0.05, 0.01, 0.001 <i>vs</i>. Bas of the same group; #,##,### P<0.05, 0.01, 0.001 <i>vs</i>. naïve at the same time point, respectively. Concentrations of plas...
The aim of this study was to examine effects of pinealectomy and melatonin administration plasma lep...
The effects of melatonin on glucose metabolism are far from understood. In rats, the biological cloc...
Aims: The effect of chronic treatment with acarbose on fasting plasma glucose, insulin, triglyceride...
<p>Comparison between naïve ZDF rats (left column, n = 5) and pinealectomized ZDF rats (two weeks af...
<p>Showing the development of hyperglycemia in ZDF rats with or without the taVNS treatment (a) and ...
<p>The total production of melatonin in taVNS treated rats may be higher since the melatonin concent...
<p>Showing that each taVNS administration (shielded area) would trigger acute and tidal melatonin se...
Melatonin plays a protective role in type 2 diabetes (T2D) through regulation of glucose me-tabolism...
Studies on rat islet preparations have shown melatonin inhibits MAO activity and thereby reduces glu...
<p>Groups of young STZ-diabetic rats were treated with TA1m DNA at 0.8 µg/gm body-weight or molar eq...
<p>Five groups of age matched rats (5–7 rats/group) weighing ∼50gm were treated intraperitoneally wi...
<p>Diabetic OLETF rats were randomly divided into two groups, a Tat-GFP treatment group and a Tat-MT...
<p>PF-04991532 increased the rate of glucose infusion in order to maintain hyperglycemia in Goto-Kak...
<p>(A) Glucose profile in IPGTT (glucose 2g/kg) before treatment (B) Glucose profile in IPGTT (gluco...
<p>(A) FBG and FINS levels in SHR/cp rats treated with 1.67 or 3.24 g/kg TNK for 7 weeks. (B) HOMA-I...
The aim of this study was to examine effects of pinealectomy and melatonin administration plasma lep...
The effects of melatonin on glucose metabolism are far from understood. In rats, the biological cloc...
Aims: The effect of chronic treatment with acarbose on fasting plasma glucose, insulin, triglyceride...
<p>Comparison between naïve ZDF rats (left column, n = 5) and pinealectomized ZDF rats (two weeks af...
<p>Showing the development of hyperglycemia in ZDF rats with or without the taVNS treatment (a) and ...
<p>The total production of melatonin in taVNS treated rats may be higher since the melatonin concent...
<p>Showing that each taVNS administration (shielded area) would trigger acute and tidal melatonin se...
Melatonin plays a protective role in type 2 diabetes (T2D) through regulation of glucose me-tabolism...
Studies on rat islet preparations have shown melatonin inhibits MAO activity and thereby reduces glu...
<p>Groups of young STZ-diabetic rats were treated with TA1m DNA at 0.8 µg/gm body-weight or molar eq...
<p>Five groups of age matched rats (5–7 rats/group) weighing ∼50gm were treated intraperitoneally wi...
<p>Diabetic OLETF rats were randomly divided into two groups, a Tat-GFP treatment group and a Tat-MT...
<p>PF-04991532 increased the rate of glucose infusion in order to maintain hyperglycemia in Goto-Kak...
<p>(A) Glucose profile in IPGTT (glucose 2g/kg) before treatment (B) Glucose profile in IPGTT (gluco...
<p>(A) FBG and FINS levels in SHR/cp rats treated with 1.67 or 3.24 g/kg TNK for 7 weeks. (B) HOMA-I...
The aim of this study was to examine effects of pinealectomy and melatonin administration plasma lep...
The effects of melatonin on glucose metabolism are far from understood. In rats, the biological cloc...
Aims: The effect of chronic treatment with acarbose on fasting plasma glucose, insulin, triglyceride...